LA/P/0064/2020 (DOI: 10.54499/LA/P/0064/2020) and PTDC/MEC-CIR/3615/2021 (DOI: 10.54499/PTDC/MEC-CIR/3615/2021))
Noveltreat 1.7 mg Pre-filled Pen is used along with a reduced-calorie diet and increased physical activity to help lower the risk of major heart-related events, such as heart attack, stroke, or cardiovascular death, in adults who have established heart disease and also have obesity or overweight
Con el tiempo, estos efectos no solo mejoran la salud metablica, sino que tambin favorecen la reduccin de peso segura y constante
is invested into improving operational efficiencies
Injection site reactions such as subcutaneous nodules were reported mainly in patients receiving exenatide OW (7.5%) and in a small minority of patients treated with dulaglutide (0.2%) and semaglutide (0.8%)
What to Expect Initial Consultation Bloodwork Personalized Treatment Plan Weekly Injections Ongoing Monitoring Or call us to discuss further